Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01828723 · ClinicalTrials.gov registry record · Phase 1
Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells
A Phase 1 study, sponsored by Antria.
- Completed
- Registry status
- Phase 1
- Development phase
- 6
- Enrollment target
NCT01828723 is a Phase 1 study that has completed, run by Antria. The registered enrollment target is 6 participants.
The verdict
NCT01828723, a Phase 1 study, has completed, sponsored by Antria.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 6 participants
- Enrollment target
Study Summary
The primary purpose of this study is to demonstrate the safety of injecting the Stromal Vascular Fraction (SVF) \[containing Adipose Derived Stem Cells (ADSCs)\] enriched fat grafts into regions of the face that require enhancement. The safety of SVF will be evaluated throughout the course of the study phase through the assessment of laboratory values, physical examinations, adverse events, safety phone calls etc.
Interventions
- BIOLOGICAL SVF
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2013-04 |
| Est. Completion | 2015-01 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01828723
The ClinicalTrials.gov registry entry for NCT01828723 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Antria, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which SVF is the first listed.
NCT01828723 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01828723 about?
NCT01828723 is a clinical study titled "Safety Study of Antria Cell Preparation Process to Enhance Facial Fat Grafting With Adipose Derived Stem Cells". The primary purpose of this study is to demonstrate the safety of injecting the Stromal Vascular Fraction (SVF) \[containing Adipose Derived Stem Cells (ADSCs)\] enriched fat grafts into regions of the face that require enhancement. The safety of SVF will be evaluated throughout the course of the st...
What is the current status of trial NCT01828723?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 6 participants. The study started on 2013-04. Estimated completion is 2015-01.
What interventions are being tested in trial NCT01828723?
The interventions under investigation include: SVF (BIOLOGICAL).
Who is sponsoring clinical trial NCT01828723?
This trial is sponsored by Antria, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.